Overall, IL-6 has been described to be upregulated in advanced BlCa patients (Chen et al., 2013; Goulet et al., 2019) and in lymph node metastasis (Andrews et al., 2002; Schuettfort et al., 2022). The gene discussed is IL6; the disease is metastatic malignant neoplasm in the lymph nodes.